Asbestos Mesothelioma Mesothelioma Treatment
Mesothelioma Alerts Conventional Treatments Experimental Treatments Mesothelioma Clinical Trials Mesothelioma Treatment by Stage Ask Your Doctor Cancer Centers Leading Mesothelioma Physicians Mesothelioma Articles & Abstracts Review Studies Case Studies Etiological Studies Diagnostic Studies Therapy Studies Mesothelioma Resources
News About ELSS Top Mesothelioma Doctors

Dr. Robert N. Taub
New York, NY; Prominent mesothelioma doctor and director of Columbia’s Mesothelioma Center...

Dr. Valerie Rusch
New York, NY; Internationally recognized thoracic surgeon has led numerous research efforts to understand how patients respond to mesothelioma treatment...

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

First Name:

Last Name:

Address:

City:

ST:

Zip:

Home Phone:

Work Phone:

Cell Phone:

Email Address:

Have you or someone you know been diagnosed with mesothelioma?

Yes   No

Mesothelioma Treatment | Articles & Abstracts

Review Studies

Malignant pleural mesothelioma: a comprehensive review.

Cancer Control. 2006 Oct;13(4):255-63.
Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR.
Thoracic Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

BACKGROUND: The incidence of malignant mesothelioma continues to increase, but the disease remains difficult to detect early and treat effectively. METHODS: The authors review the pathogenesis, incidence, clinical presentation, diagnosis, pathology, and both standard and experimental treatments for mesothelioma. RESULTS: When possible, surgery (video-assisted thoracoscopy, pleurectomy/decortication, or extrapleural pneumonectomy) is utilized. Effects on underlying structures limit application of radiation therapy, but some systemic agents are beginning to enhance survival. CONCLUSIONS: The disease is expected to increase in incidence till 2020, so awareness of this entity as a possible diagnosis should be heightened. In patients with advanced disease, several newer antitumor agents are already showing a capability of extending survival so it is not unreasonable to expect further progress in this area.

PMID: 17075562 [PubMed - indexed for MEDLINE]
Click here to order or save article

If you have any questions regarding treatment options or your legal rights, please contact us.